Loading…
FGM and NISM share 3.8% of their holdings.
| Side by side | SCHC | FGM | NISM |
|---|---|---|---|
| Strategy | International · Ex-US broad | International · Region & country | International · Ex-US broad |
| Expense ratio | 0.06% | 0.80% | 0.70% |
| Cost per year on $10k | $6 | $80 | $70 |
| Trailing 12-mo yield | 3.45% | 1.84% | 0.24% |
| Income per year on $10k | $345 | $184 | $24 |
| YTD | +7.2% | −5.0% | — |
| 1 year | +10.0% | +0.9% | — |
| 3 years · per year | +20.7% | +22.1% | — |
| 5 years · per year | +5.6% | +3.6% | — |
| Worst drop · 1Y | −12.5% | −18.3% | — |
| Volatility · 1Y | 16.9% | 21.1% | — |
| Holdings | 2,332 | 41 | 88 |
| Assets | $5.5B | $86M | $26M |
| Leverage | None | None | None |
| Since | 2010 | 2012 | 2026 |
Highlighted = best in the row. Returns include dividends.